38
Participants
Start Date
April 4, 2017
Primary Completion Date
January 24, 2018
Study Completion Date
January 24, 2018
4 mg CLS-TA Suprachoriodal Injection
CLS-TA, 40 mg/mL (4 mg in 100 microliters), will be administered as a single injection at 2 timepoints
Virginia Eye Consultants, Norfolk
Marietta Eye Clinic, Marietta
Retina Group of Florida, Fort Lauderdale
Midwest Eye Retina Practicing at Midwest Eye Institute, Indianapolis
Texas Retina Associates, Dallas
Retina Consultants of Houston, Houston
Retinal Consultants of Arizona, Phoenix
Retina-Vitreous Associates Medical Group, Beverly Hills
Northern California Retina Vitreous Associates Medical Group, Inc., Mountain View
Ophthalmic Consultants of Boston, Boston
Lead Sponsor
Clearside Biomedical, Inc.
INDUSTRY